Argonaut Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$848K |
| 2 |
Royal Caribbean
RCL
|
+$791K |
| 3 |
American Express
AXP
|
+$498K |
| 4 |
PACCAR
PCAR
|
+$446K |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$384K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.1M |
| 2 |
Community Health Systems
CYH
|
+$2.03M |
| 3 |
JPMorgan Chase
JPM
|
+$964K |
| 4 |
Microsoft
MSFT
|
+$929K |
| 5 |
The Greenbrier Companies
GBX
|
+$538K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.73% |
| 2 | Healthcare | 12.93% |
| 3 | Financials | 4.95% |
| 4 | Technology | 4.26% |
| 5 | Consumer Discretionary | 3.9% |
Similar funds
Argonaut Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Argonaut Capital Management held 30 positions worth $62.2M, down 10% from $69.3M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Argonaut Capital Management withdrew a net $8.69M in Q1 2015, closing 5 positions. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $39.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Argonaut Capital Management opened a new position in BioMarin Pharmaceuticals worth $997K.
- Argonaut Capital Management's largest Q1 2015 buy was BioMarin Pharmaceuticals: 8,000 shares worth $997K.
- Argonaut Capital Management added most to Rite Aid Corporation in Q1 2015, an estimated $195K increase.
- Argonaut Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2015, selling an estimated $39.1M.
- Argonaut Capital Management's ten largest holdings make up 79% of its $62.2M portfolio in Q1 2015.
- Argonaut Capital Management opened 8 new positions and closed 5 in Q1 2015.
- Argonaut Capital Management's portfolio value fell 10% quarter-over-quarter to $62.2M.
Based on Argonaut Capital Management's 13F filing for Q1 2015, filed 15 May 2015.